Activators and target genes of Rel/NF-κB transcription factors
The DOI matches its Crossref record; 340 of the 340 references it cites were found in a registry or an index.
Abstract
The vertebrate transcription factor NF-kappaB is induced by over 150 different stimuli. Active NF-kappaB, in turn, participates in the control of transcription of over 150 target genes. Because a large variety of bacteria and viruses activate NF-kappaB and because the transcription factor regulates the expression of inflammatory cytokines, chemokines, immunoreceptors, and cell adhesion molecules, NF-kappaB has often been termed a 'central mediator of the human immune response'. This article contains a complete listing of all NF-kappaB inducers and target genes described to date. The collected data argue that NF-kappaB functions more generally as a central regulator of stress responses. In addition, NF-kappaB activation blocks apoptosis in several cell types. Coupling stress responsiveness and anti-apoptotic pathways through the use of a common transcription factor may result in increased cell survival following stress insults.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“After demonstrating the ability to screen genetic knockouts for optical phenotypes, we sought to identify genes required for activation of NF-κB, a family of transcription factors (p50, p52, p65, RelB and c-Rel) that translocate to the nucleus in response to a host of stimuli (Gewurz et al., 2012; Hayden and Ghosh, 2012; Pahl, 1999).”
From Optical Pooled Screens in Human Cells (2019) · cites this paper as Pahl, 1999
In the citing paper
“Most inflammatory mediators either activate or target the nuclear factor 'kappa-light-chain-enhancer' of activated B-cells (NF-κB) which is a key transcriptional regulator of the inflammatory response.[18,19]”
From Nuclear receptors in liver fibrosis (2021) · cites this paper as [19]
Citations
Cites
1 retracted
Gruss, H., Brach, M., & Herrmann, F. (1992) · Blood · doi:10.1182/blood.v80.10.2563.2563 · Cited by 29
RetractedSchreck, R., Rieber, P., & Baeuerle, P. A. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb07761.x · Cited by 3,816 · cited 1×
“…combined with HeNe irradiation Haas et al., 1998 g Radiation Brach et al., 1991a Oxidative Stress Butyl Peroxide Munroe et al., 1995 Hydrogen Peroxide Schreck et al., 1991 Ozone Haddad et al., 1996 Pervanadate Imbert et al., 1996 Reoxygenation Rupec and Baeuerle, 1995 Environmental Hazards…”
BackgroundAn Essential Role for NF-κB in Preventing TNF-α-Induced Cell Death
Beg, A. A., & Baltimore, D. (1996) · Science · doi:10.1126/science.274.5288.782 · Cited by 3,047 · cited 3×
“The observation that several stimuli, among them tumor necrosis factor a (TNFa) and binding to the IgM receptor (or cross linking of the receptor with antibodies), can lead both to NF-kB activation (Table 1) and to apoptosis (Laster et al., 1988; Hasbold and Klaus, 1990) suggested that NF-kB induction was pro-apoptoti…”
BackgroundInfluentialMultiple nuclear factors interact with the immunoglobulin enhancer sequences
Sen, R., & Baltimore, D. (1986) · Cell · doi:10.1016/0092-8674(86)90346-6 · Cited by 2,752 · cited 8×
“…and Baeuerle unpublished observation N-methyl-D-aspartate Guerrini et al., 1995 Nocodazol Rosette and Karin, 1995a Okadaic Acid Thevenin et al., 1991 PHA Sen and Baltimore, 1986b Phorbol ester Sen and Baltimore, 1986a Podophyllotoxin Rosette and Karin, 1995a Pyrogallol Adcock et al., 1994…”
BackgroundInfluentialTNF- and Cancer Therapy-Induced Apoptosis: Potentiation by Inhibition of NF-κB
Wang, C.-Y., Mayo, M. W., & Baldwin, A. S. (1996) · Science · doi:10.1126/science.274.5288.784 · Cited by 2,617 · cited 4×
“Likewise, the observations that NF-kB regulates transcription of the cyclin D1 gene (Guttridge et al., 1999; Hinz et al., 1999) and may also participate in cyclin D3 gene transcription (Wang et al., 1996b) are very intriguing.”
BackgroundInfluentialSuppression of TNF-α-Induced Apoptosis by NF-κB
Van Antwerp, D. J., Martin, S. J., Kafri, T., Green, D. R., & Verma, I. M. (1996) · Science · doi:10.1126/science.274.5288.787 · Cited by 2,581
Hydrogen peroxide mediates amyloid β protein toxicity
Behl, C. (1994) · Cell · doi:10.1016/0092-8674(94)90131-7 · Cited by 2,074 · cited 1×
“…Das and White, 1997 Modi®ed Proteins Advanced glycated end products (AGEs) Yan et al., 1994; Wautier et al., 1994 Amyloid Protein Fragment (bA4) Behl et al., 1994 Maleylated BSA Misra et al., 1996 Modi®ed (Oxidized)LDL Rajavashisth et al., 1995; Andalibi et al., 1993 Overexpressed Proteins…”
BackgroundAn inducible transcription factor activates expression of human immunodeficiency virus in T cells
Nabel, G., & Baltimore, D. (1987) · Nature · doi:10.1038/326711a0 · Cited by 2,041 · cited 1×
“…Brooks et al., 1995 CMV Cytomegalovirus Sambucetti et al., 1989 EBV (Wp promoter) Epstein-Barr virus Sugano et al., 1997 HIV-1 Human immunode®ciency virus Nabel and Baltimore, 1987; Gri n et al., 1989 HSV Herpes simplex virus Rong et al., 1992 JC Virus Polyoma virus Ranganathan and Khalili,…”
BackgroundInducibility of κ immunoglobulin enhancer-binding protein NF-κB by a posttranslational mechanism
Sen, R., & Baltimore, D. (1986) · Cell · doi:10.1016/0092-8674(86)90807-x · Cited by 1,993 · cited 8×
“…and Baeuerle unpublished observation N-methyl-D-aspartate Guerrini et al., 1995 Nocodazol Rosette and Karin, 1995a Okadaic Acid Thevenin et al., 1991 PHA Sen and Baltimore, 1986b Phorbol ester Sen and Baltimore, 1986a Podophyllotoxin Rosette and Karin, 1995a Pyrogallol Adcock et al., 1994…”
BackgroundInfluentialOsborn, L., Kunkel, S., & Nabel, G. J. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.7.2336 · Cited by 1,621 · cited 3×
“…NSI Mo att et al., 1996 continued Table 1 continued Condition Reference Eukaryotic parasite Theileria parva Ivanov et al., 1989 (In¯ammatory) Cytokines IL-1 Osborn et al., 1989 IL-2 Hazan et al., 1990 IL-12 Grohmann et al., 1998 IL-15 McDonald et al., 1998 IL-17 Shalom-Barak et al., 1998 IL-18…”
BackgroundInfluential
Research works printed but not linked: 9
- Grove M and Plumbi M. . 1993 Mol. Cell. Biol. 13: 5276–5289. · doi:10.1128/mcb.13.9.5276-5289.1993 · Paper page
- Harada H, Takahashi E, Itoh S, Harada K, Hori TA and Taniguchi T. . 1994 Mol. Cell. Biol. 14: 1500–1509. · doi:10.1128/mcb.14.2.1500-1509.1994 · Paper page
- Li J and Brasier AR. . 1996 Mol. Endocrinol. 10: 252–264. · doi:10.1210/mend.10.3.8833654 · Paper page
- Libermann TA and Baltimore D. . 1990 Mol. Cell Biol. 10: 2327–2334. · doi:10.1128/mcb.10.5.2327 · Paper page
- Nishizawa M and Nagata S. . 1990 Mol. Cell. Biol. 10: 2002–2011. · doi:10.1128/mcb.10.5.2002-2011.1990 · Paper page
- Pahl HL. . 1999 Phys. Rev., in press.
- Schreck R and Baeuerle PA. . 1990 Mol. Cell. Biol. 10: 1281–1286. · doi:10.1128/mcb.10.3.1281-1286.1990 · Paper page
- Tewari M, Dobrzanski P, Mohn KL, Cressmann DE, Hsu J-C, Bravo R and Taub R. . 1992 Mol. Cell. Biol. 12: 2898–2908. · doi:10.1128/mcb.12.6.2898-2908.1992 · Paper page
- Worm MM, Tsytsykova A and Geha RS. . 1998 Eur. J. Immunol. 28: 901–906. · doi:10.1002/(sici)1521-4141(199803)28:03<901::aid-immu901>3.0.co;2-s
Cited by
Items 401–500 of 1,021
Associations Among -TrCP, an E3 Ubiquitin Ligase Receptor, -Catenin, and NF- B in Colorectal Cancer
Ougolkov, A., Zhang, B., Yamashita, K., Bilim, V., Mai, M., Fuchs, S. Y., & Minamoto, T. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh219 · Cited by 164
The p75 neurotrophin receptor: multiple interactors and numerous functions
Gentry, J. J., Barker, P. A., & Carter, B. D. (2004) · Progress in Brain Research · doi:10.1016/s0079-6123(03)46002-0 · Cited by 158
Inflammation and cancer: Breast cancer as a prototype
Mantovani, A., Marchesi, F., Porta, C., Sica, A., & Allavena, P. (2007) · The Breast · doi:10.1016/j.breast.2007.07.013 · Cited by 159
Toll-like receptor signaling and stages of addiction
Crews, F. T., Walter, T. J., Coleman, L. G., & Vetreno, R. P. (2017) · Psychopharmacology · doi:10.1007/s00213-017-4560-6 · Cited by 156
Murga, C., Zohar, M., Teramoto, H., & Gutkind, J. S. (2002) · Oncogene · doi:10.1038/sj.onc.1205036 · Cited by 162
“In particular, the activation of the NF-kB transcription factor, which is often stimulated by small GTPases (Perona et al., 1997), constitutes a wellestablished anti-apoptotic route (Pahl, 1999).”
BackgroundHypothalamic inflammation: a double‐edged sword to nutritional diseases
Cai, D., & Liu, T. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2011.06388.x · Cited by 159
Methotrexate Inhibits NF‐κB Activity Via Long Intergenic (Noncoding) RNA–p21 Induction
Spurlock, C. F., Tossberg, J. T., Matlock, B. K., Olsen, N. J., & Aune, T. M. (2014) · Arthritis & Rheumatology · doi:10.1002/art.38805 · Cited by 161
“In contrast, NF- B is a prosurvival and proinflammatory transcription factor (21).”
BackgroundKodach, L. L., Bos, C. L., Durán, N., Peppelenbosch, M. P., Ferreira, C. V., & Hardwick, J. C. H. (2006) · Carcinogenesis · doi:10.1093/carcin/bgi307 · Cited by 160
RAGE Activation by S100P in Colon Cancer Stimulates Growth, Migration, and Cell Signaling Pathways
Fuentes, M. K., Nigavekar, S. S., Arumugam, T., Logsdon, C. D., Schmidt, A. M., Park, J. C., & Huang, E. H. (2007) · Diseases of the Colon & Rectum · doi:10.1007/s10350-006-0850-5 · Cited by 161
NF-κB in Mammary Gland Development and Breast Cancer
Cao, Y., & Karin, M. (2003) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/a:1025905008934 · Cited by 158
“The target genes regulated by NF-κB are quite diverse, including immunoregulatory and inflammatory genes, anti-apoptotic genes, genes that positively regulate cell proliferation, and genes that encode negative regulators of NF-κB (8,9).”
Woo, M., Park, J., Choi, I., Kim, W., & Kim, H. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05430.x · Cited by 162
Minimal model of spiky oscillations in NF-κB signaling
Krishna, S., Jensen, M. H., & Sneppen, K. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604085103 · Cited by 161
Clinical implications of growth factors in flexor tendon wound healing
Hsu, C., & Chang, J. (2004) · The Journal of Hand Surgery · doi:10.1016/j.jhsa.2004.04.020 · Cited by 162
Ni, H., Ergin, M., Huang, Q., Qin, J., Amin, H. M., Martinez, R. L., Saeed, S., Barton, K., & Alkan, S. (2001) · British Journal of Haematology · doi:10.1046/j.1365-2141.2001.03102.x · Cited by 159
“Activation occurs when NFkB is released from IkB and translocated to the nucleus (Pahl, 1999).”
BackgroundRahman, S. M., Schroeder‐Gloeckler, J. M., Janssen, R. C., Jiang, H., Qadri, I., Maclean, K. N., & Friedman, J. E. (2007) · Hepatology · doi:10.1002/hep.21614 · Cited by 159
NF-κB: A Stress-Regulated Switch for Cell Survival
Piva, R., Belardo, G., & Santoro, M. G. (2006) · Antioxidants & Redox Signaling · doi:10.1089/ars.2006.8.478 · Cited by 153
Kim, M., Seong, A., Yoo, J., Jin, C., Lee, Y., Kim, Y. J., Lee, J., Jun, W. J., & Yoon, H. (2011) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201100262 · Cited by 155
Degradation of Nuclear Factor Kappa B during Foot-and-Mouth Disease Virus Infection
Santos, T. D. L., Segundo, F. D.-S., & Grubman, M. J. (2007) · Journal of Virology · doi:10.1128/jvi.01467-07 · Cited by 174
Sweeney, C., Li, L., Shanmugam, R., Bhat-Nakshatri, P., Jayaprakasan, V., Baldridge, L. A., Gardner, T., Smith, M., Nakshatri, H., & Cheng, L. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-0571-03 · Cited by 158
Romio, M., Reinbeck, B., Bongardt, S., Hüls, S., Burghoff, S., & Schrader, J. (2011) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00385.2010 · Cited by 151
Robe, P. A., Bentires-Alj, M., Bonif, M., Rogister, B., Deprez, M., Haddada, H., Khac, M.-T. N., Jolois, O., Erkmen, K., Merville, M.-P., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0392 · Cited by 154
Role of Tax protein in human T-cell leukemia virus type-I leukemogenicity
Azran, I., Schavinsky-Khrapunsky, Y., & Aboud, M. (2004) · Retrovirology · doi:10.1186/1742-4690-1-20 · Cited by 153
“A substantial part of Tax oncogenic potential is attributed to its ability to activate transcription factors of the NF-κB family, since these factors regulate the expression of numerous cellular genes [81] associated with diverse biological processes, such as embryonic development, immune and inflammatory responses, c…”
BackgroundCytosolic detection of the bacterial metabolite HBP activates TIFA-dependent innate immunity
Gaudet, R. G., Sintsova, A., Buckwalter, C. M., Leung, N., Cochrane, A., Li, J., Cox, A. D., Moffat, J., & Gray-Owen, S. D. (2015) · Science · doi:10.1126/science.aaa4921 · Cited by 154
RelB Forms Transcriptionally Inactive Complexes with RelA/p65
Marienfeld, R. B., May, M. J., Berberich, I., Serfling, E., Ghosh, S., & Neumann, M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301945200 · Cited by 174
Qian, Y., Guan, T., Huang, M., Cao, L., Li, Y., Cheng, H., Jin, H., & Yu, D. (2012) · Neurochemistry International · doi:10.1016/j.neuint.2012.03.011 · Cited by 164
Modulation of NF-κB Signaling as a Therapeutic Target in Autoimmunity
Herrington, F., Carmody, R. J., & Goodyear, C. S. (2015) · SLAS DISCOVERY · doi:10.1177/1087057115617456 · Cited by 167
Novel NEMO/IκB Kinase and NF-κB Target Genes at the Pre-B to Immature B Cell Transition
Li, J., Peet, G. W., Balzarano, D., Li, X., Massa, P., Barton, R. W., & Marcu, K. B. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100846200 · Cited by 154
Regulation and Pathological Role of p53 in Cisplatin Nephrotoxicity
Jiang, M., & Dong, Z. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.139162 · Cited by 162
Artemisinin inhibits inducible nitric oxide synthase and nuclear factor NF‐kB activation
Aldieri, E., Atragene, D., Bergandi, L., Riganti, C., Costamagna, C., Bosia, A., & Ghigo, D. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)00905-0 · Cited by 152
Critical role of NF-κB in pancreatic cancer
Prabhu, L., Mundade, R., Korc, M., Loehrer, P. J., & Lu, T. (2014) · Oncotarget · doi:10.18632/oncotarget.2624 · Cited by 148
“Activation of NF-κB leads to the upregulation of RAGE expression in PDAC cells [35].”
BackgroundVolt, H., García, J. A., Doerrier, C., Díaz‐Casado, M. E., Guerra‐Librero, A., López, L. C., Escames, G., Tresguerres, J. A., & Acuña‐Castroviejo, D. (2016) · Journal of Pineal Research · doi:10.1111/jpi.12303 · Cited by 149
NF‐κB/Egr‐1/Gadd45 are sequentially activated upon UVB irradiation to mediate epidermal cell death
Thyss, R., Virolle, V., Imbert, V., Peyron, J., Aberdam, D., & Virolle, T. (2004) · The EMBO Journal · doi:10.1038/sj.emboj.7600501 · Cited by 167
“…through the induction of proapoptotic genes that code for the death receptor Fas and its ligand (Kasibhatla et al, 1998; Barkett and Gilmore, 1999; Pahl, 1999). p65(RelA) was shown to associate with histone deacetylases to repress antiapoptotic genes in particular settings such as UVC…”
BackgroundROS in the local and systemic pathogenesis of COPD
LANGEN, R. C. J., Korn, S. H., & Wouters, E. F. �. (2003) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(03)00316-2 · Cited by 173
Krappmann, D., Wegener, E., Sunami, Y., Esen, M., Thiel, A., Mordmuller, B., & Scheidereit, C. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.14.6488-6500.2004 · Cited by 152
Tumor-Derived p53 Mutants Induce NF-κB2 Gene Expression
Scian, M. J., Stagliano, K. E. R., Anderson, M. A. E., Hassan, S., Bowman, M., Miles, M. F., Deb, S. P., & Deb, S. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.22.10097-10110.2005 · Cited by 148
Amit, S., & Ben‐Neriah, Y. (2003) · Seminars in Cancer Biology · doi:10.1016/s1044-579x(02)00096-2 · Cited by 160
Lee, S. H., Lee, S. Y., Son, D. J., Lee, H., Yoo, H. S., Song, S., Oh, K. W., Han, D. C., Kwon, B. M., & Hong, J. T. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.11.013 · Cited by 172
Chahbouni, M., Escames, G., Venegas, C., Sevilla, B., García, J. A., López, L. C., Muñoz‐Hoyos, A., Molina‐Carballo, A., & Acuña‐Castroviejo, D. (2010) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2010.00752.x · Cited by 151
NF-κB Activation in Airways Modulates Allergic Inflammation but Not Hyperresponsiveness
Poynter, M. E., Cloots, R. H. E., van Woerkom, T., Butnor, K. J., Vacek, P. M., Taatjes, D. J., Irvin, C. G., & Janssen-Heininger, Y. M. W. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.11.7003 · Cited by 152
“The transcription factor NF- B is considered a master regulator of inflammation and immune processes (1, 2) and has been widely implicated in the pathophysiology of asthma.”
BackgroundDouble-edged swords as cancer therapeutics: simultaneously targeting p53 and NF-κB pathways
Dey, A., Tergaonkar, V., & Lane, D. P. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2759 · Cited by 170
Activation of Nuclear Factor-κB by High Molecular Weight and Globular Adiponectin
Haugen, F., & Drevon, C. A. (2007) · Endocrinology · doi:10.1210/en.2007-0370 · Cited by 150
Poynter, M. E., Irvin, C. G., & Janssen-Heininger, Y. M. W. (2002) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)62559-x · Cited by 152
Molecular Mechanisms of System Control of NF-κB Signaling by IκBα
Ferreiro, D. U., & Komives, E. A. (2010) · Biochemistry · doi:10.1021/bi901948j · Cited by 168
Aberrant NF-KappaB Expression in Autism Spectrum Condition: A Mechanism for Neuroinflammation
Young, A. M. H., Campbell, E., Lynch, S., Suckling, J., & Powis, S. J. (2011) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2011.00027 · Cited by 146
Malmberg, K.-J., Arulampalam, V., Ichihara, F., Petersson, M., Seki, K., Andersson, T., Lenkei, R., Masucci, G., Pettersson, S., & Kiessling, R. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.5.2595 · Cited by 151
“This observation is in line with recent reports, showing that induction of IL-10 production is regulated by Stat 3, and not by NF- B (17, 34).”
BackgroundResultKim, E. H., & Surh, Y. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.07.030 · Cited by 166
Liu, P., Kimmoun, E., Legrand, A., Sauvanet, A., Degott, C., Lardeux, B., & Bernuau, D. (2002) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00064-8 · Cited by 147
Guess, J. C., & McCance, D. J. (2005) · Journal of Virology · doi:10.1128/jvi.79.23.14852-14862.2005 · Cited by 145
The Role of Inflammation in Skin Cancer
Maru, G. B., Gandhi, K., Ramchandani, A. G., & Kumar, G. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-3-0348-0837-8_17 · Cited by 157
“Several NF-κB-dependent genes present in the skin are essential to the initiation of cutaneous inflammation, including genes for different chemokines (IL-1, IL-6, TNF) and cytokines, intercellular adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1), urokinase plasminogen activator (uPA), and E-sel…”
BackgroundPivarcsi, A., Nagy, I., Koreck, A., Kis, K., Kenderessy, A. S., Széll, M., DOBOZY, A., & Kemény, L. V. (2005) · Microbes and Infection · doi:10.1016/j.micinf.2005.03.016 · Cited by 170
Bellido, C., López‐Miranda, J., Blanco‐Colio, L. M., Pérez‐Martínez, P., Muriana, F. J. G., Martín-Ventura, J. L., Marín, C., Gómez, P., Fuentes, F. J., Egido, J., et al. (2004) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/80.6.1487 · Cited by 175
“This process activates genes involved in immune and inflammatory responses, such as interleukins, growth factors, and cytokines (8).”
BackgroundShishodia, S., Sethi, G., Konopleva, M., Andreeff, M., & Aggarwal, B. B. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2044 · Cited by 148
García‐Piñeres, A., Lindenmeyer, M. T., & Merfort, I. (2004) · Life Sciences · doi:10.1016/j.lfs.2004.01.024 · Cited by 148
Suppressive Effects of the Kahweol and Cafestol on Cyclooxygenase-2 Expression in Macrophages
Kim, J. Y., Jung, K. S., & Jeong, H. G. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.05.070 · Cited by 146
Sarisozen, C., Abouzeid, A. H., & Torchilin, V. P. (2014) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2014.07.001 · Cited by 145
Negative regulation of NF-κB p65 activity by serine 536 phosphorylation
Pradère, J.-P., Hernandez, C., Koppe, C., Friedman, R. A., Luedde, T., & Schwabe, R. F. (2016) · Science Signaling · doi:10.1126/scisignal.aab2820 · Cited by 141
Ablation of endothelial Pfkfb3 protects mice from acute lung injury in LPS-induced endotoxemia
Wang, L., Cao, Y., Gorshkov, B. A., Zhou, Y., Yang, Q., Xu, J., Ma, Q., Zhang, X., Wang, J., Mao, X., et al. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104292 · Cited by 150
“HPAECs transfected with siCTRL or siPFKFB3 were treated with LPS for 4 hours; qPCR assays showed that the mRNA levels of ICAM-1, VCAM-1 and E-selectin were decreased in PFKFB3 knockdown HPAECs compared with those of control cells (Fig.”
BackgroundInfluentialSekino, N., Selim, M., & Shehadah, A. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02464-4 · Cited by 138
Thumkeo, D., Punyawatthananukool, S., Prasongtanakij, S., Matsuura, R., Arima, K., Nie, H., Yamamoto, R., Aoyama, N., Hamaguchi, H., Sugahara, S., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110914 · Cited by 152
Martin-Oliva, D., Aguilar-Quesada, R., O'Valle, F., Muñoz-Gámez, J. A., Martínez-Romero, R., García del Moral, R., Ruiz de Almodóvar, J. M., Villuendas, R., Piris, M. A., & Oliver, F. J. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3050 · Cited by 138
NF-κB Mediates IL-1β– and IL-17A–Induced MUC5B Expression in Airway Epithelial Cells
Fujisawa, T., Chang, M. M.-J., Velichko, S., Thai, P., Hung, L., Huang, F., Phuong, N. S., Chen, Y., & Wu, R. (2010) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2009-0313oc · Cited by 148
Akari, H., Bour, S., Kao, S., Adachi, A., & Strebel, K. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.9.1299 · Cited by 146
Chen, F., Wang, M., O'Connor, J. P., He, M., Tripathi, T., & Harrison, L. E. (2003) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10668 · Cited by 151
Tegeder, I., Niederberger, E., Schmidt, R., Kunz, S., Gühring, H., Ritzeler, O., Michaelis, M., & Geißlinger, G. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.3118-03.2004 · Cited by 165
Anti-inflammatory mechanism of ginseng saponins in activated microglia
Park, J., Park, E., Kim, D., Jung, K., Jung, J.-S., Lee, E.-J., Hyun, J., Kang, J. L., & Kim, H.-S. (2009) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2009.01.020 · Cited by 145
“NF-κB is an important upstream modulator of cytokine and iNOS expression in microglia (Pahl, 1999).”
BackgroundHattori, Y., Hattori, K., Suzuki, T., & Matsuda, N. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.02.040 · Cited by 153
“Many of the proinflammatory genes are regulated by κB sites in the DNA (Pahl, 1999).”
Pacifico, F., & Leonardi, A. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.07.032 · Cited by 165
Zienolddiny, S., Ryberg, D., Maggini, V., Skaug, V., Canzian, F., & Haugen, A. (2004) · International Journal of Cancer · doi:10.1002/ijc.11695 · Cited by 148
The role of the ubiquitin/proteasome system in cellular responses to radiation
McBride, W. H., Iwamoto, K. S., Syljuåsen, R. G., Pervan, M., & Pajonk, F. (2003) · Oncogene · doi:10.1038/sj.onc.1206676 · Cited by 153
“Another survival pathway that is frequently upregulated in cancer is directed by NFk-B, a transcription factor that is sequestered in the cytoplasm by IkB inhibitors until activated to translocate into the nucleus (Wang et al., 1997; Pahl, 1999; Bussell, 2001).”
BackgroundThe ubiquitin-proteasome pathway as a therapeutic target for muscle wasting.
Tisdale, M. J. (2005) · PubMed · Cited by 178
Joint single-cell measurements of nuclear proteins and RNA in vivo
Chung, H., Parkhurst, C. N., Magee, E. M., Phillips, D., Habibi, E., Chen, F., Yeung, B. Z., Waldman, J., Artis, D., & Regev, A. (2021) · Nature Methods · doi:10.1038/s41592-021-01278-1 · Cited by 144
Zheng, M., Ekmekçioglu, S., Walch, E. T., Tang, C., & Grimm, E. A. (2004) · Melanoma Research · doi:10.1097/01.cmr.0000129374.76399.19 · Cited by 144
Adam, J. K., Odhav, B., & Bhoola, K. D. (2003) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(03)00056-1 · Cited by 170
The Nuclear Factor κB pathway: A link to the immune system in the radiation response
Hellweg, C. E. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.02.019 · Cited by 158
“The list of NF-κB activators is long and comprises diverse endogenous and exogenous ligands and physical and chemical stresses [4,38,39].”
BackgroundTakada, Y., Andreeff, M., & Aggarwal, B. B. (2005) · Blood · doi:10.1182/blood-2004-12-4589 · Cited by 151
NF-κB activation by double-strand breaks
Habraken, Y., & Piette, J. G. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.07.015 · Cited by 156
Lukas-Croisier, C., Lasala, C., Nicaud, J., Bedecarrás, P., Kumar, T. R., Dutertre, M., Matzuk, M. M., Picard, J., Josso, N., & Rey, R. A. (2003) · Molecular Endocrinology · doi:10.1210/me.2002-0186 · Cited by 199
Kim, D.-S., Park, S. S., Nam, B., Kim, I.-H., & Kim, S. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1521 · Cited by 143
“23). NF-nB promotes the survival of cells following DNA damage and plays a role in neoplastic transformation by inhibiting p53 gene expression ( 24 ).”
BackgroundAmin, M. A., Haas, C. S., Zhu, K., Mansfield, P. J., Kim, M. J., Lackowski, N. P., & Koch, A. E. (2006) · Blood · doi:10.1182/blood-2005-05-2011 · Cited by 141
Nguyen, D. P., Li, J., Yadav, S. S., & Tewari, A. K. (2013) · British Journal of Urology · doi:10.1111/bju.12488 · Cited by 155
The AAA+ ATPase p97, a cellular multitool
Stach, L., & Freemont, P. S. (2017) · Biochemical Journal · doi:10.1042/bcj20160783 · Cited by 151
Huang, Z., Du, G., Huang, X., Li, H., Han, X., Xu, B., Zhang, Y., Yu, M., Qin, Y., Xia, Y., et al. (2018) · EBioMedicine · doi:10.1016/j.ebiom.2018.11.015 · Cited by 145
Regulation of the cell cycle and apoptosis by the oncogenes of adenovirus
White, E. P. (2001) · Oncogene · doi:10.1038/sj.onc.1204861 · Cited by 162
“TNF-a for example, activates not only caspase-8 but also NF-kB, which upregulates the transcription of a number of pro-survival Bcl-2 family members and IAPs (Barkett and Gilmore, 1999; Pahl, 1999).”
BackgroundMohamed, S. I. A., Jantan, I., & Haque, M. A. (2017) · International Immunopharmacology · doi:10.1016/j.intimp.2017.07.010 · Cited by 151
“Stimulation of NFκB signaling pathway was reported to promote the tumor growth as well as angiogenesis and metastasis of cancer cells [147].”
Sack, M. N. (2002) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(02)00176-6 · Cited by 168
Characterization of NF-κΒ/IκΒ Proteins in Zebra Fish and Their Involvement in Notochord Development
Correa, R. G., Tergaonkar, V., Ng, J. K., Dubova, I., Izpisúa‐Belmonte, J. C., & Verma, I. M. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.12.5257-5268.2004 · Cited by 142
“More than 150 different stimuli, including bacterial lipopolysaccharides (LPS), proinflammatory cytokines (tumor necrosis factor alpha [TNF-] and interleukin-1 [IL-1]), hormones, and mitogenic agents, are able to promote NF- activation ( 29 ).”
BackgroundBurton‐Freeman, B. M., & Sesso, H. D. (2014) · Advances in Nutrition · doi:10.3945/an.114.005231 · Cited by 152
den Kamp, C. M. O., LANGEN, R. C. J., Snepvangers, F. J. M., de Theije, C. C., Schellekens, J. M., Laugs, F., Dingemans, A. C., & Schols, A. M. W. J. (2013) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.113.058388 · Cited by 140
Zeng, H., Wu, H., Sloane, V., Jones, R., Yu, Y., Lin, P., Gewirtz, A. T., & Neish, A. S. (2006) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00273.2005 · Cited by 136
Djavaheri-Mergny, M., Javelaud, D., Wietzerbin, J., & Besançon, F. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.10.082 · Cited by 134
Barr, J. L., Sharma, C. S., Sarkar, S., Wise, K., Dong, L., Periyakaruppan, A., & Ramesh, G. T. (2006) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-006-9333-1 · Cited by 149
A Noisy Paracrine Signal Determines the Cellular NF-κB Response to Lipopolysaccharide
Lee, T. K., Denny, E. M., Sanghvi, J. C., Gaston, J. E., Maynard, N. D., Hughey, J. J., & Covert, M. W. (2009) · Science Signaling · doi:10.1126/scisignal.2000599 · Cited by 139
“As in other studies (20, 28), we focused on the first 4 hours of stimulation to minimize the extensive downstream effects that follow NF-kB activation (16).”
Bower, A. M., Marquez, S. L., & de Mejía, E. G. (2015) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2013.805713 · Cited by 139
“Together, these studies suggest that extract of basil may inhibit nuclear factor-kB (NFkB) binding activity, since genes for many of these cytokines are downstream of this transcription factor (Pahl, 1999).”
BackgroundZhong, X., Li, X., Liu, F., Tan, H., & Shang, D. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.07.110 · Cited by 140
Muscle Wasting and Impaired Muscle Regeneration in a Murine Model of Chronic Pulmonary Inflammation
Langen, R. C. J., Schols, A. M. W. J., Kelders, M. C. J. M., van der Velden, J. L. J., Wouters, E. F. M., & Janssen-Heininger, Y. M. W. (2006) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2006-0103oc · Cited by 137
Li, S., Ye, L., Yu, X., Xu, B., Li, K., Zhu, X., Liu, H., Wu, X., & Kong, L. (2009) · Virology · doi:10.1016/j.virol.2009.06.039 · Cited by 149
Zhou, H. Y., Shin, E. M., Guo, L. Y., Youn, U. J., Bae, K., Kang, S. S., Zou, L. B., & Kim, Y. S. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.02.044 · Cited by 138
The multiple facets of drug resistance: one history, different approaches
Niero, E. L., Rocha-Sales, B., Lauand, C., Cortez, B. A., de Souza, M. M., Rezende-Teixeira, P., Urabayashi, M. S., Martens, A. A., Neves, J. H., & Machado-Santelli, G. M. (2014) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-33-37 · Cited by 137
Soy isoflavone phyto-pharmaceuticals in interleukin-6 affections
Dijsselbloem, N., Berghe, W. V., Naeyer, A. D., & Haegeman, G. (2004) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.05.036 · Cited by 151
“A key player in IL6 gene expression is the transcription factor NF-kB, of which the transcriptional activity is regulated at multiple levels [99,132–135].”
BackgroundTanaka, K.-I., Namba, T., Arai, Y., Fujimoto, M., Adachi, H., Sobue, G., Takeuchi, K., Nakai, A., & Mizushima, T. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704081200 · Cited by 138
Metadata
- Authors
- Pahl, H. L.
- Affiliations
- University of Freiburg (DE)
- Corresponding author
- Pahl, Heike L
- ORCID
- Pahl, Heike L
- Venue
- Oncogene
- Published
- 1999-11-22
- Volume
- 18
- Issue
- 49
- Pages
- 6853-6866
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2038890616
- Cited by
- 3,727
- References
- 333
- Citations by year
- 2026: 36 · 2025: 57 · 2024: 73 · 2023: 69 · 2022: 118 · 2021: 126 · 2020: 117 · 2019: 131 · 2018: 147 · 2017: 143 · 2016: 147 · 2015: 167 · 2014: 170 · 2013: 169 · 2012: 199
- FWCI
- 34.77
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Oncogene (publishedVersion)
- PubMed (publishedVersion)
- FreiDok plus (Universitätsbibliothek Freiburg) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Keywords
- NF-κB, Rel transcription factors, target genes, inflammatory cytokines, chemokines, immunoreceptors, adhesion molecules, immune response, stress response, apoptosis, cell survival, transcriptional regulation
- MeSH terms
- Animals, DNA, Humans, Immunity, Stress, Physiological, NF-kappa B
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.